Literature DB >> 27372215

Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations.

Nicolas Carriere1,2, Jean-Louis Bourriez1,3, Arnaud Delval1,3, Philippe Derambure1,3, Luc Defebvre1,2, Kathy Dujardin1,2.   

Abstract

BACKGROUND: Impulse control disorders (ICDs) in Parkinson's disease (PD) are related to treatment with dopamine agonists, which is thought to deregulate the dopaminergic mesolimbic pathway and impair reward evaluation. EEG studies in healthy controls (HCs) have suggested that the increase in theta power observed after negative outcome is a marker of reward processing.
OBJECTIVE: To compare outcome-locked, event-related spectral perturbation in a gambling task in PD patients with and without ICDs and in HCs.
METHODS: Twelve PD patients with ICDs, 12 PD patients without ICDs and 14 HCs underwent EEG while performing a gambling task. The groups were compared in terms of (i) the peak EEG power in the theta (4-7 Hz), alpha (8-14 Hz) and beta (15-30 Hz) frequency bands between 200 and 500 ms after the outcome, and (ii) time-frequency plots at Fz, FCz and Cz.
RESULTS: Positive outcomes were associated with greater theta power than negative outcomes in patients without ICDs and in HCs, but not in patients with ICDs. Patients with ICDs and HCs displayed greater theta power following unexpectedly high outcomes. HCs displayed greater beta power following high amplitude than low amplitude outcomes, whereas patients with ICD showed the opposite pattern.
CONCLUSIONS: In PD, ICDs are associated with (i) weaker modulation of frontocentral theta power by reward valence, (ii) greater frontocentral theta power following unexpected, high outcomes, and (iii) a reversal of the effect of risk on beta oscillations. These observations are consistent with an impairment in prediction error computation in the medial prefrontal cortex.

Entities:  

Keywords:  Parkinson disease; and conduct disorders; brain waves; disruptive; electroencephalography; gambling; impulse control; reward

Mesh:

Substances:

Year:  2016        PMID: 27372215     DOI: 10.3233/JPD-160828

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  1 in total

Review 1.  The Top 5 Neurotransmitters from a Clinical Neurologist's Perspective.

Authors:  Daniel Kondziella
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.